Finance

Lists
1681:HKG
Consun Pharmaceutical Group Ltd
HK$13.15
-0.30%
(-0.040) 1D
Sep 9, 4:08:04 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1681...
Open
HK$13.18
High
HK$13.33
Low
HK$13.06
Mkt. cap
11.03B
Avg. vol.
0.00
Volume
1.54M
Dividend
5.93%
Quarterly dividend
HK$0.20
Ex-dividend date
Sep 4, 2025
P/E ratio
8.14
52-wk high
HK$19.49
52-wk low
HK$12.31
EPS
HK$1.61
Shares outstanding
875.19M
No. of employees
3K
Open
HK$13.18
High
HK$13.33
Low
HK$13.06
Mkt. cap
11.03B
Avg. vol.
0.00
Volume
1.54M
Dividend
5.93%
Quarterly dividend
HK$0.20
Ex-dividend date
Sep 4, 2025
P/E ratio
8.14
52-wk high
HK$19.49
52-wk low
HK$12.31
EPS
HK$1.61
Shares outstanding
875.19M
No. of employees
3K
About Consun Pharmaceutical Group Ltd
CEO-
Employees2.85K
Founded1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
924.38M
924.38M
892.34M
892.34M
Cost of goods sold
195.16M
195.16M
166.31M
166.31M
Cost of revenue
195.16M
195.16M
166.31M
166.31M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
412.59M
412.59M
398.41M
398.41M
Operating expense
410.59M
410.59M
394.20M
394.20M
Total operating expenses
605.75M
605.75M
560.51M
560.51M
Operating income
318.63M
318.63M
331.83M
331.83M
Other non operating income
-
-
-
-
EBT including unusual items
330.59M
330.59M
349.17M
349.17M
EBT excluding unusual items
331.38M
331.38M
349.76M
349.76M
Income tax expense
37.45M
37.45M
50.10M
50.10M
Effective tax rate
11.33%
11.33%
14.35%
14.35%
Other operating expenses
-1.19M
-1.19M
-5.01M
-5.01M
Net income
289.88M
289.88M
297.65M
297.65M
Net profit margin
31.36%
31.36%
33.36%
33.36%
Earnings per share
-
-
-
-
Interest and investment income
21.11M
21.11M
20.36M
20.36M
Interest expense
-946.00K
-946.00K
-1.34M
-1.34M
Net interest expenses
20.16M
20.16M
19.01M
19.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
332.28M
332.28M
345.74M
345.74M
Gain or loss from assets sale
965.50K
965.50K
-
-
AI content may include mistakes. Learn more
Google apps